Balyasny Asset Management LLC Cv Rx, Inc. Transaction History
Balyasny Asset Management LLC
- $58 Billion
- Q3 2024
A detailed history of Balyasny Asset Management LLC transactions in Cv Rx, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 506,398 shares of CVRX stock, worth $6.53 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
506,398
Previous 443,114
14.28%
Holding current value
$6.53 Million
Previous $5.31 Million
16.02%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding CVRX
# of Institutions
86Shares Held
14.4MCall Options Held
56.3KPut Options Held
41.8K-
Johnson & Johnson New Brunswick, NJ4.1MShares$52.9 Million11.52% of portfolio
-
Nea Management Company, LLC Timonium, MD2.37MShares$30.6 Million1.6% of portfolio
-
Black Rock Inc. New York, NY876KShares$11.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA824KShares$10.6 Million0.0% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT683KShares$8.81 Million0.85% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $265M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...